A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...
GLP-1 agonist drugs like Ozempic and Wegovy have surged in popularity during the last couple of years for their ability to help patients shed weight quickly and potentially reduce inflammation. While ...
Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.
Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration ...